Epsylam DT

Epsylam DT Use In Pregnancy & Lactation



Aurobindo Pharma


Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: Women exposed to lamotrigine monotherapy during pregnancy cannot exclude an increased risk of congenital malformations.
In therapy with lamotrigine is considered necessary during pregnancy, the lowest possible therapeutic dose is recommended.
Lactation: Lamotrigine has been reported to pass into breast milk in highly variable concentrations, resulting in total Lamotrigine levels in infants of up to approximately 50% of the mother's. Therefore, in some breast-fed infants, serum concentrations of Lamotrigine may reach levels at which pharmacological effects occur. Among a limited group of exposed infants, no adverse effects were observed.
The potential benefits of breast-feeding should be weighed against the potential risk of adverse effects occurring in the infant. Should a woman decide to breastfeed while on therapy with Lamotrigine, the infants should be monitored for adverse effects.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in